"The Global Diabetes Care Devices Market was valued at USD 62.34 billion in 2025 and is projected to reach USD 137.11 billion by 2034, growing at a CAGR of 9.15%."
The diabetes care devices market encompasses a range of tools and technologies designed to help individuals monitor and manage blood glucose levels, insulin delivery, and related health metrics. Core offerings include blood glucose meters (BGM), continuous glucose monitoring (CGM) systems, insulin pumps, smart insulin pens, and integrated digital platforms or apps that sync data for tracking and analysis. Adoption is driven by rising diabetes prevalence globally, demand for improved glycemic control, and the push toward self-management and remote monitoring. Innovations in sensor accuracy, wearability, and connectivity have transformed conventional care CGMs now offer real-time, trend-based glucose insights with minimal calibration, while insulin delivery devices increasingly integrate with mobile apps to optimize dosing. Manufacturers are also focusing on user-friendly design, minimally invasive sensors, disposable patch pumps, and interoperable systems that can communicate with telemedicine portals and electronic health records. As patients and payers seek outcomes-driven value, the market is shifting toward platforms that offer predictive alerts, data analytics, and closed-loop automation toward an eventual artificial pancreas.
Market dynamics are shaped by regulatory support for digital health, reimbursement models that favor preventative care, and patient demand for convenience and personalization. CGMs are increasingly being reimbursed for broader patient groups, expanding access beyond type 1 diabetes to include type 2 and gestational diabetes. Smart pens and connected insulin pumps offer benefits in dose tracking and adherence, especially when paired with insulin-on-board calculations and decision support. Telehealth integration enables remote patient coaching, early warnings for hypo/hyperglycemia, and reduced clinician burden. The forecast points to continuing growth in CGM adoption, rising uptake of automated and semi-automated insulin delivery systems, and expansion of smartphone-based dashboards that aggregate glucose, activity, and nutritional data. Recent developments include the launch of skin-mimetic adhesives for longer CGM wear, compact dual-chamber patch systems combining insulin and glucagon, and AI-based dose-recommendation engines that enhance safety and personalization in diabetes self-management.
Report Scope
| Parameter | Detail |
|---|---|
| Base Year | 2024 |
| Estimated Year | 2025 |
| Forecast Period | 2026-2034 |
| Market Size-Units | USD billion/Million |
| Market Splits Covered | By Type ,By Type of Expenditure ,By Product ,By Type Of Testing ,By End User |
| Countries Covered | North America (USA, Canada, Mexico) Europe (Germany, UK, France, Spain, Italy, Rest of Europe) Asia-Pacific (China, India, Japan, Australia, Rest of APAC) The Middle East and Africa (Middle East, Africa) South and Central America (Brazil, Argentina, Rest of SCA) |
| Analysis Covered | Latest Trends, Driving Factors, Challenges, Supply-Chain Analysis, Competitive Landscape, Company Strategies |
| Customization | 10% free customization(up to 10 analyst hours) to modify segments, geographies, and companies analyzed |
| Post-Sale Support | 4 analyst hours, available up to 4 weeks |
| Delivery Format | The Latest Updated PDF and Excel Datafile |
Regional Insights
North America Diabetes Care Devices Market
North America’s market is propelled by high diabetes prevalence, strong reimbursement for CGM and insulin pump therapy, and rapid integration of digital health across provider networks. Lucrative opportunities exist in interoperable ecosystems that link CGM, pumps, and smart pens to decision-support software, as well as in remote patient monitoring programs contracted by payers and health systems. Latest trends include factory-calibrated CGMs with longer wear times, patch pumps targeting type 2 insulin users, and pharmacy-channel expansion that shortens time-to-therapy. The forecast points to continued shift from fingerstick meters to continuous sensing, broader uptake of hybrid closed-loop systems, and increased participation of primary care in technology-enabled titration. Recent developments feature app-based insulin initiation pathways, AI-driven hypoglycemia prediction embedded in patient apps, and real-world evidence collaborations to demonstrate cost offsets from improved time-in-range.
Asia Pacific Diabetes Care Devices Market
Asia Pacific exhibits fast growth driven by rising urbanization, expanding middle-class access to care, and government initiatives to digitize chronic disease management. Companies can tap opportunities in affordable CGM alternatives, starter pump programs for insulin-intensive type 2 patients, and multilingual apps tailored to local diets and clinical workflows. Latest trends include smartphone-centric monitoring bundles, hospital-to-home transition kits with education modules, and partnerships with e-pharmacies for subscription replenishment. The forecast indicates strong penetration of connected pens and intermittently scanned sensors, alongside gradual scaling of automated insulin delivery where reimbursement matures. Recent developments highlight local manufacturing to reduce device costs, cloud platforms compliant with regional data rules, and pilot programs combining nutrition guidance with glucose analytics for culturally aligned care.
Europe Diabetes Care Devices Market
Europe’s market dynamics are anchored by robust public reimbursement, stringent safety standards, and active adoption of interoperable, data-secure solutions. Opportunities concentrate in algorithmic titration tools for primary care, integrated CGM–pump platforms for pediatric and adult cohorts, and procurement models that reward outcomes such as time-in-range. Latest trends include sensor miniaturization with extended wear, interoperable “iCGM/iPump” frameworks, and seamless data flows into electronic records to support population-level management. The forecast suggests steady migration to closed-loop therapy, expanded access for type 2 insulin users, and broader home-care support to alleviate clinic burden. Recent developments include payer-backed remote monitoring pathways, carbon-aware device and packaging initiatives, and cross-border registries generating comparative effectiveness insights to guide national formulary decisions.
Key Market Insights
The diabetes care devices market is expanding rapidly due to the global rise in diabetes prevalence and the growing emphasis on self-monitoring and proactive disease management. Technological advancements are enabling more accurate, less invasive, and user-friendly solutions that improve patient adherence and quality of life.
Continuous glucose monitoring (CGM) systems are emerging as a dominant segment, offering real-time glucose readings, trend analysis, and predictive alerts. These devices significantly reduce the need for frequent fingersticks and provide data that supports personalized treatment decisions and better glycemic control.
Integration of insulin delivery devices, such as pumps and smart pens, with digital health platforms is transforming diabetes management. Connectivity features allow dose tracking, insulin-on-board calculations, and remote data sharing with healthcare providers for enhanced treatment oversight.
Closed-loop and hybrid closed-loop systems, also known as artificial pancreas solutions, are gaining traction. These systems combine CGM data with automated insulin delivery, reducing patient intervention and improving time-in-range metrics for better long-term outcomes.
Telehealth adoption is driving the integration of diabetes care devices with virtual coaching and monitoring services. This approach supports remote consultations, timely intervention, and data-driven treatment adjustments without frequent in-person visits.
Wearability and comfort are major product development priorities, with manufacturers introducing smaller, lighter devices, flexible sensors, and adhesives that support extended wear without skin irritation, improving patient experience and compliance.
AI and machine learning are being embedded into diabetes care devices to provide predictive analytics, detect glucose variability patterns, and offer personalized dosing recommendations, enhancing safety and optimizing treatment regimens.
Reimbursement policies are expanding CGM and smart insulin delivery coverage, particularly for type 2 diabetes patients who require intensive insulin therapy, broadening the addressable market and increasing adoption rates.
Data interoperability is becoming a critical differentiator, with devices designed to sync seamlessly with smartphones, fitness trackers, nutrition apps, and electronic health record systems to deliver holistic patient insights.
Competition is intensifying as established medtech companies and new entrants launch innovative, cost-effective solutions targeting underserved populations. This includes disposable patch pumps, integrated CGM–pump systems, and devices designed for low-resource healthcare settings.
Diabetes Care Devices Market Segments Covered In The Report
By Type
- Blood Glucose Test Strips
- Insulin Pens
- Syringes
- Pumps And Injectors
- Lancing Devices And Equipment
- Continuous Glucose Monitoring Devices And Equipment
- Blood Glucose Meter
By Type of Expenditure
- Public
- Private
By Product
- Instruments/Equipment
- Disposables
By Type Of Testing
- Point Of Care (POC) Testing
- Non-Point Of Care (POC) Testing
By End User
- Hospitals And Clinics
- Diagnostic Laboratories
- Other End Users
By Geography
- North America (USA, Canada, Mexico)
- Europe (Germany, UK, France, Spain, Italy, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Vietnam, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Key Companies Covered
Recent Industry Developments
Jul 2025 — Insulet reported a strong second-quarter performance, with Omnipod tubeless insulin pump sales sharply up and full-year revenue guidance revised upward, bolstered by increased uptake among early Type 2 diabetes users and improved CGM app integration.
Jun 2025 — A clinical trial published in the New England Journal of Medicine demonstrated that automated insulin delivery (AID) systems significantly improved glucose control in adults with Type 2 diabetes compared to traditional care plus continuous glucose monitoring.
May 2025 — Abbott’s FreeStyle Libre continuous glucose monitoring technology was linked to a substantial reduction in hospitalizations from heart-related complications among people with Type 1 and Type 2 diabetes, marking a milestone for CGMs in cardiovascular outcomes.
May 2025 — Medtronic announced its plan to spin off its diabetes care business into a standalone, publicly traded company, enabling focused investment and growth in its diabetes technology portfolio.
Apr 2025 — Dexcom obtained FDA clearance for its G7 15-Day continuous glucose monitoring system, offering the longest sensor wear time and enhanced accuracy for users aged 18 and older.
Apr 2025 — Abbott entered into a groundbreaking agreement to integrate Libre CGM data directly into Epic’s electronic health record systems, creating a seamless flow of glucose information in clinical workflows.
Apr 2025 — Medtronic submitted an FDA application for an interoperable insulin pump compatible with Abbott’s CGM platform, signaling advancement toward plug-and-play diabetes device ecosystems.
Apr 2025 — Senseonics and Sequel formed a partnership to develop a one-year wearable continuous glucose monitor intended for use in automated insulin delivery systems, aiming to enhance convenience and reduce sensor change frequency.
Mar 2025 — Dexcom expanded its Dexcom U program, empowering more NCAA athletes with continuous glucose monitoring devices and launching a sports camp that brings together college athletes and middle schoolers living with diabetes.
What You Receive
• Global Diabetes Care Devices market size and growth projections (CAGR), 2024- 2034• Impact of recent changes in geopolitical, economic, and trade policies on the demand and supply chain of Diabetes Care Devices.
• Diabetes Care Devices market size, share, and outlook across 5 regions and 27 countries, 2025- 2034.
• Diabetes Care Devices market size, CAGR, and Market Share of key products, applications, and end-user verticals, 2025- 2034.
• Short and long-term Diabetes Care Devices market trends, drivers, restraints, and opportunities.
• Porter’s Five Forces analysis, Technological developments in the Diabetes Care Devices market, Diabetes Care Devices supply chain analysis.
• Diabetes Care Devices trade analysis, Diabetes Care Devices market price analysis, Diabetes Care Devices Value Chain Analysis.
• Profiles of 5 leading companies in the industry- overview, key strategies, financials, and products.
• Latest Diabetes Care Devices market news and developments.
The Diabetes Care Devices Market international scenario is well established in the report with separate chapters on North America Diabetes Care Devices Market, Europe Diabetes Care Devices Market, Asia-Pacific Diabetes Care Devices Market, Middle East and Africa Diabetes Care Devices Market, and South and Central America Diabetes Care Devices Markets. These sections further fragment the regional Diabetes Care Devices market by type, application, end-user, and country.
1.1 List of Tables
1.2 List of Figures
2. Diabetes Care Devices Market Latest Trends, Drivers and Challenges, 2024 - 2034
2.1 Diabetes Care Devices Market Overview
2.2 Market Strategies of Leading Diabetes Care Devices Companies
2.3 Diabetes Care Devices Market Insights, 2024 - 2034
2.3.1 Leading Diabetes Care Devices Types, 2024 - 2034
2.3.2 Leading Diabetes Care Devices End-User industries, 2024 - 2034
2.3.3 Fast-Growing countries for Diabetes Care Devices sales, 2024 - 2034
2.4 Diabetes Care Devices Market Drivers and Restraints
2.4.1 Diabetes Care Devices Demand Drivers to 2034
2.4.2 Diabetes Care Devices Challenges to 2034
2.5 Diabetes Care Devices Market- Five Forces Analysis
2.5.1 Diabetes Care Devices Industry Attractiveness Index, 2024
2.5.2 Threat of New Entrants
2.5.3 Bargaining Power of Suppliers
2.5.4 Bargaining Power of Buyers
2.5.5 Intensity of Competitive Rivalry
2.5.6 Threat of Substitutes
3. Global Diabetes Care Devices Market Value, Market Share, and Forecast to 2034
3.1 Global Diabetes Care Devices Market Overview, 2024
3.2 Global Diabetes Care Devices Market Revenue and Forecast, 2024 - 2034 (US$ billion)
3.3 Global Diabetes Care Devices Market Size and Share Outlook By Type, 2024 - 2034
3.4 Global Diabetes Care Devices Market Size and Share Outlook By Type of Expenditure, 2024 - 2034
3.5 Global Diabetes Care Devices Market Size and Share Outlook By Product, 2024 – 2034
3.6 Global Diabetes Care Devices Market Size and Share Outlook By Type Of Testing, 2024 - 2034
3.7 Global Diabetes Care Devices Market Size and Share Outlook by Region, 2024 - 2034
4. Asia Pacific Diabetes Care Devices Market Value, Market Share and Forecast to 2034
4.1 Asia Pacific Diabetes Care Devices Market Overview, 2024
4.2 Asia Pacific Diabetes Care Devices Market Revenue and Forecast, 2024 - 2034 (US$ billion)
4.3 Asia Pacific Diabetes Care Devices Market Size and Share Outlook By Type, 2024 - 2034
4.4 Asia Pacific Diabetes Care Devices Market Size and Share Outlook By Type of Expenditure, 2024 - 2034
4.5 Asia Pacific Diabetes Care Devices Market Size and Share Outlook By Product, 2024 – 2034
4.6 Asia Pacific Diabetes Care Devices Market Size and Share Outlook By Type Of Testing, 2024 - 2034
4.7 Asia Pacific Diabetes Care Devices Market Size and Share Outlook by Country, 2024 - 2034
5. Europe Diabetes Care Devices Market Value, Market Share, and Forecast to 2034
5.1 Europe Diabetes Care Devices Market Overview, 2024
5.2 Europe Diabetes Care Devices Market Revenue and Forecast, 2024 - 2034 (US$ billion)
5.3 Europe Diabetes Care Devices Market Size and Share Outlook By Type, 2024 - 2034
5.4 Europe Diabetes Care Devices Market Size and Share Outlook By Type of Expenditure, 2024 - 2034
5.5 Europe Diabetes Care Devices Market Size and Share Outlook By Product, 2024 – 2034
5.6 Europe Diabetes Care Devices Market Size and Share Outlook By Type Of Testing, 2024 - 2034
5.7 Europe Diabetes Care Devices Market Size and Share Outlook by Country, 2024 - 2034
6. North America Diabetes Care Devices Market Value, Market Share and Forecast to 2034
6.1 North America Diabetes Care Devices Market Overview, 2024
6.2 North America Diabetes Care Devices Market Revenue and Forecast, 2024 - 2034 (US$ billion)
6.3 North America Diabetes Care Devices Market Size and Share Outlook By Type, 2024 - 2034
6.4 North America Diabetes Care Devices Market Size and Share Outlook By Type of Expenditure, 2024 - 2034
6.5 North America Diabetes Care Devices Market Size and Share Outlook By Product, 2024 – 2034
6.6 North America Diabetes Care Devices Market Size and Share Outlook By Type Of Testing, 2024 - 2034
6.7 North America Diabetes Care Devices Market Size and Share Outlook by Country, 2024 - 2034
7. South and Central America Diabetes Care Devices Market Value, Market Share and Forecast to 2034
7.1 South and Central America Diabetes Care Devices Market Overview, 2024
7.2 South and Central America Diabetes Care Devices Market Revenue and Forecast, 2024 - 2034 (US$ billion)
7.3 South and Central America Diabetes Care Devices Market Size and Share Outlook By Type, 2024 - 2034
7.4 South and Central America Diabetes Care Devices Market Size and Share Outlook By Type of Expenditure, 2024 - 2034
7.5 South and Central America Diabetes Care Devices Market Size and Share Outlook By Product, 2024 – 2034
7.6 South and Central America Diabetes Care Devices Market Size and Share Outlook By Type Of Testing, 2024 - 2034
7.7 South and Central America Diabetes Care Devices Market Size and Share Outlook by Country, 2024 - 2034
8. Middle East Africa Diabetes Care Devices Market Value, Market Share and Forecast to 2034
8.1 Middle East Africa Diabetes Care Devices Market Overview, 2024
8.2 Middle East and Africa Diabetes Care Devices Market Revenue and Forecast, 2024 - 2034 (US$ billion)
8.3 Middle East Africa Diabetes Care Devices Market Size and Share Outlook By Type, 2024 - 2034
8.4 Middle East Africa Diabetes Care Devices Market Size and Share Outlook By Type of Expenditure, 2024 - 2034
8.5 Middle East Africa Diabetes Care Devices Market Size and Share Outlook By Product, 2024 – 2034
8.6 Middle East Africa Diabetes Care Devices Market Size and Share Outlook By Type Of Testing, 2024 - 2034
8.7 Middle East Africa Diabetes Care Devices Market Size and Share Outlook by Country, 2024 - 2034
9. Diabetes Care Devices Market Structure
9.1 Key Players
9.2 Diabetes Care Devices Companies - Key Strategies and Financial Analysis
9.2.1 Snapshot
9.2.3 Business Description
9.2.4 Products and Services
9.2.5 Financial Analysis
10. Diabetes Care Devices Industry Recent Developments
11 Appendix
11.1 Publisher Expertise
11.2 Research Methodology
11.3 Annual Subscription Plans
11.4 Contact Information
Get Free Sample
At OG Analysis, we understand the importance of informed decision-making in today's dynamic business landscape. To help you experience the depth and quality of our market research reports, we offer complimentary samples tailored to your specific needs.
Start Now! Please fill the form below for your free sample.
Why Request a Free Sample?
Evaluate Our Expertise: Our reports are crafted by industry experts and seasoned analysts. Requesting a sample allows you to assess the depth of research and the caliber of insights we provide.
Tailored to Your Needs: Let us know your industry, market segment, or specific topic of interest. Our free samples are customized to ensure relevance to your business objectives.
Witness Actionable Insights: See firsthand how our reports go beyond data, offering actionable insights and strategic recommendations that can drive your business forward.
Embark on your journey towards strategic decision-making by requesting a free sample from OG Analysis. Experience the caliber of insights that can transform the way you approach your business challenges.
FAQ's
The Global Diabetes Care Devices Market is estimated to generate USD 62.34 billion in revenue in 2025.
The Global Diabetes Care Devices Market is expected to grow at a Compound Annual Growth Rate (CAGR) of 9.15% during the forecast period from 2025 to 2034.
The Diabetes Care Devices Market is estimated to reach USD 137.11 billion by 2034.
Didn’t find what you’re looking for? TALK TO OUR ANALYST TEAM
Need something within your budget? NO WORRIES! WE GOT YOU COVERED!
